Cargando…

Long-term effectiveness of tocilizumab in patients with rheumatoid arthritis, stratified by number of previous treatment failures with biologic agents: results from the German RABBIT cohort

In Germany, Tocilizumab (TCZ) is used for the treatment of rheumatoid arthritis both in biologic-naïve patients and those with previous failures of biologic disease-modifying antirheumatic drugs (bDMARDs). The long-term effectiveness and retention rates of TCZ in patients with different numbers of p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baganz, Lisa, Richter, Adrian, Kekow, Jörn, Bussmann, Arnold, Krause, Andreas, Stille, Carsten, Listing, Joachim, Zink, Angela, Strangfeld, Anja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Cohort Studies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854739/ https://www.ncbi.nlm.nih.gov/pubmed/29143933 http://dx.doi.org/10.1007/s00296-017-3870-7

Ejemplares similares

Clinical and functional remission: even though biologics are superior to conventional DMARDs overall success rates remain low – results from RABBIT, the German biologics register
por: Listing, Joachim, et al.
Publicado: (2006)

Sustainability of Rituximab Therapy in Different Treatment Strategies: Results of a 3-Year Followup of a German Biologics Register
por: Richter, Adrian, et al.
Publicado: (2014)

Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab
por: Listing, Joachim, et al.
Publicado: (2015)

Serious adverse events and the risk of stroke in patients with rheumatoid arthritis: results from the German RABBIT cohort
por: Meissner, Y, et al.
Publicado: (2017)

Impact of disease activity and treatment of comorbidities on the risk of myocardial infarction in rheumatoid arthritis
por: Meissner, Yvette, et al.
Publicado: (2016)

Factors associated with treatment satisfaction in patients with rheumatoid arthritis: data from the biological register RABBIT
por: Schäfer, Martin, et al.
Publicado: (2020)

Health-related quality of life in patients with long-standing rheumatoid arthritis in the era of biologics: data from the German biologics register RABBIT
por: Gerhold, Kerstin, et al.
Publicado: (2015)

Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritis
por: Schäfer, Martin, et al.
Publicado: (2020)

Corrigendum to: Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritis
por: Schäfer, Martin, et al.
Publicado: (2020)

Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT
por: Strangfeld, Anja, et al.
Publicado: (2010)

Risk of herpes zoster (shingles) in patients with rheumatoid arthritis under biologic, targeted synthetic and conventional synthetic DMARD treatment: data from the German RABBIT register
por: Redeker, Imke, et al.
Publicado: (2022)

Evaluation of the RABBIT Risk Score for serious infections
por: Zink, A, et al.
Publicado: (2014)

Incidence of facial nerve palsies stratified by DMARD treatment in patients with rheumatoid arthritis: data from the RABBIT register
por: Meissner, Yvette, et al.
Publicado: (2020)

Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs
por: Strangfeld, A, et al.
Publicado: (2017)

Risk of major adverse cardiovascular events in patients with rheumatoid arthritis treated with conventional synthetic, biologic and targeted synthetic disease-modifying antirheumatic drugs: observational data from the German RABBIT register
por: Meissner, Yvette, et al.
Publicado: (2023)

Body mass index distribution in rheumatoid arthritis: a collaborative analysis from three large German rheumatoid arthritis databases
por: Albrecht, Katinka, et al.
Publicado: (2016)

Impact of treatment with biologic DMARDs on the risk of sepsis or mortality after serious infection in patients with rheumatoid arthritis
por: Richter, A, et al.
Publicado: (2016)

In-hospital mortality in SARS-CoV-2 stratified by the use of corticosteroid
por: Alotaibi, Naser, et al.
Publicado: (2022)

Profile of the multicenter cohort of the German Cancer Consortium’s Clinical Communication Platform
por: Maier, Daniel, et al.
Publicado: (2023)

Framework and baseline examination of the German National Cohort (NAKO)
por: Peters, Annette, et al.
Publicado: (2022)

Statistical Analysis in the German National Cohort (NAKO) – Specific Aspects and General Recommendations
por: Kuss, Oliver, et al.
Publicado: (2022)

Cohort Profile: The German Ageing Survey (DEAS)
por: Klaus, Daniela, et al.
Publicado: (2017)

Depressive symptoms are associated with fatigue, poorer functional status and less engagement in sports in axSpA and PsA: an analysis from the RABBIT-SpA cohort
por: Reich, Andreas, et al.
Publicado: (2023)

Mobile Responsive App—A Useful Additional Tool for Data Collection in the German Pregnancy Register Rhekiss?
por: Richter, Jutta G., et al.
Publicado: (2021)

In-hospital mortality in SARS-CoV-2 stratified by sex diffrences: A retrospective cross-sectional cohort study
por: Al-Jarallah, Mohammed, et al.
Publicado: (2022)

The German National Pandemic Cohort Network (NAPKON): rationale, study design and baseline characteristics
por: Schons, Maximilian, et al.
Publicado: (2022)

Cohort Profile: Stratifying Resilience and Depression Longitudinally (STRADL): a questionnaire follow-up of Generation Scotland: Scottish Family Health Study (GS:SFHS)
por: Navrady, L B, et al.
Publicado: (2018)

The transplant cohort of the German center for infection research (DZIF Tx-Cohort): study design and baseline characteristics
por: Karch, André, et al.
Publicado: (2021)

Cohort profile: The lidA Cohort Study—a German Cohort Study on Work, Age, Health and Work Participation
por: Hasselhorn, Hans Martin, et al.
Publicado: (2014)

Neues aus dem RABBIT-Register
por: Meißner, Yvette, et al.
Publicado: (2021)

Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?
por: Strangfeld, A, et al.
Publicado: (2011)

Amount of polyhydramnios attributable to diabetes may be less than previously reported
por: Moore, Lisa E
Publicado: (2017)

Surgical management of hydatid cyst disease of the liver: An improvement from our previous experience?
por: Zaharie, Florin, et al.
Publicado: (2023)

Comparison of patients with axial PsA and patients with axSpA and concomitant psoriasis: an analysis of the German register RABBIT-SpA
por: Regierer, Anne Constanze, et al.
Publicado: (2023)

Multitarget stool DNA tests increases colorectal cancer screening among previously noncompliant Medicare patients
por: Prince, Mark, et al.
Publicado: (2017)

Rituximab is more effective than second anti-TNF therapy in rheumatoid arthritis patients and previous TNFα blocker failure
por: Kekow, Joern, et al.
Publicado: (2012)

High burden of polypharmacy and comorbidity in persons with psoriatic arthritis: an analysis of claims data, stratified by age and sex
por: Albrecht, Katinka, et al.
Publicado: (2023)

Prevalence of rheumatoid arthritis among hospital workers in the north of Jordan: Preliminary report of a hospital-based cohort study
por: Alawneh, Khaldoon M., et al.
Publicado: (2020)

Predictors for response to electronic patient-reported outcomes in routine care in patients with rheumatoid arthritis: a retrospective cohort study
por: Wiegel, Jimmy, et al.
Publicado: (2023)

Relieving the bile ducts prior to pancreatoduodenectomy – A retrospective cohort study
por: Farooqui, Waqas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_djgs1u3qvgjtf0sk48uf3e1nsh